Axion Cleared Of False Advertising Before Agilent Patent Trial
A Delaware federal court granted summary judgment in favor of Axion BioSystems on false advertising claims brought by Agilent Technologies under the Lanham Act, finding no genuine dispute of material fact that Axion’s advertising deceived customers. The ruling, issued by U.S. District Ju...